Announced
Completed
Financials
Sources
Tags
United States
Biotechnology
life sciences
Minority
Acquisition
Cross Border
Friendly
Single Bidder
Private Equity
Venture Capital
Private
Completed
Synopsis
RA Capital Management, a multi-stage investment manager company, and Andera Partners, an asset management firm, led a $118m Series B round in Mineralys Therapeutics, a private, clinical-stage biopharmaceutical company, with participation from RTW Investments, Rock Springs Capital, SR One Capital Management, Sectoral Asset Management, Ysios Capital, HealthCor Management, Boulder Ventures, Catalys Pacific, Samsara BioCapital, HBM Healthcare Investments and Adams Street Partners. “We are excited to have co-led this financing with Andera partners and look forward to helping Mineralys progress on the promise of MLS-101 for the treatment of hypertension,” Derek DiRocco, RA Capital Management Partner.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.